Stocks
Immunome (IMNM) R&D US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 8.82 | 7.49 | 14.1 | 23.3 | 80.8 | 253.0 | |||
| Changes by years, y/y, % | +28% | -15% | +88% | +65% | +247% | +63.7% | |||
Immunome. R&D, bln rub
Immunome. R&D, changes, %
Immunome. R&D, sum by quarters, bln rub
Immunome (IMNM) R&D US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D, bln rub | 3.82 | 90.2 | 127.1 | 29.1 | 6.71 | 253.0 | ||
| Changes by years, y/y, % | -27% | +2 021% | +3 147% | +409% | +75% | |||
| Changes by quarters, q/q, % | -33% | +2 259% | +41% | -77% | -77% | |||
